Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Selecta Biosciences, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Selecta Biosciences, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Selecta Biosciences, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Selecta Biosciences, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| Selecta Biosciences, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 9 | 2 |
| Selecta Biosciences, Inc., Pharmaceuticals &Healthcare, Deal Details | 11 | 24 |
| Asset Purchase | 11 | 1 |
| Selecta Biosciences Acquires Rights to Virexxa from Kevelt | 11 | 1 |
| Venture Financing | 12 | 1 |
| Selecta Biosciences Raises USD38 Million in Series E Financing | 12 | 2 |
| Selecta Biosciences Raises More than USD20 Million in Venture Financing | 14 | 2 |
| Selecta Biosciences Raises USD4.4 Million in Venture Financing | 16 | 1 |
| Selecta Biosciences Raises USD6 Million in Venture Financing | 17 | 1 |
| Selecta Biosciences Raises USD5.3 Million in Venture Financing | 18 | 1 |
| Selecta Biosciences Secures US$47 Million In Series D Financing Round | 19 | 2 |
| Selecta Biosciences Raises US$15 Million In Series C Financing Round | 21 | 2 |
| Partnerships | 23 | 1 |
| Selecta Biosciences Enters into Research Agreement with Genethon | 23 | 1 |
| Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi | 24 | 2 |
| Juvenile Diabetes Research Foundation Enters Into Research Collaboration With Selecta Biosciences | 26 | 2 |
| Licensing Agreements | 28 | 1 |
| Selecta Biosciences Enters into Licensing Agreement with Massachusetts Eye and Ear Infirmary | 28 | 1 |
| Selecta Biosciences Exercises Option for Licensing Agreement with Sanofi | 29 | 1 |
| Selecta Biosciences Enters into Licensing Agreement with 3SBio for Pegsiticase | 30 | 1 |
| Selecta Biosciences Enters Into Licensing Agreement With Sanofi To Develop Antigen-Specific Immunotherapies | 31 | 2 |
| Equity Offering | 33 | 1 |
| Selecta Biosciences Raises USD70 Million in IPO | 33 | 2 |
| Selecta Biosciences, Inc. - Key Competitors | 35 | 1 |
| Key Employees | 36 | 1 |
| Locations And Subsidiaries | 37 | 1 |
| Head Office | 37 | 1 |
| Appendix | 38 | 1 |
| Methodology | 38 | 1 |
| About GlobalData | 38 | 1 |
| Contact Us | 38 | 1 |
| Disclaimer | 38 | 1 |